<span item_type="fundamental" item_id="fa1789cfaceeef406ef03f5b8be9680b" counter_id="ST/US/WGSWW" env="prod"></span><span item_type="announcement" item_id="576479454845470721" env="prod"></span><p>營收：截至 2025 財年 Q3，公佈值為 1.17 億美元。</p><p>每股收益：截至 2025 財年 Q3，公佈值為 -0.27 美元。</p><p>息税前利潤：截至 2025 財年 Q3，公佈值為 -2.69 百萬美元。</p><p></p><h3>收入</h3><ul><li>第三季度收入為 1.167 億美元，同比增長 52%。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span><span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025earningspresentati.htm"></span></li><li>外顯子組和基因組測試收入為 9890 萬美元，同比增長 65%。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span><span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025earningspresentati.htm"></span></li></ul><h3>外顯子組和基因組測試量</h3><ul><li>外顯子組和基因組測試結果量為 25,702，同比增長 33%。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li></ul><h3>毛利率</h3><ul><li>調整後的毛利率擴大至 74%，高於 2024 年第三季度的 64%。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span><span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025earningspresentati.htm"></span></li><li>GAAP 毛利率為 72%。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li></ul><h3>運營費用</h3><ul><li>調整後的總運營費用為 7120 萬美元，佔第三季度收入的 61%，相比 2024 年第三季度佔收入的 62%。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li><li>GAAP 運營費用為 8780 萬美元。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li></ul><h3>淨收入</h3><ul><li>調整後的淨收入為 1470 萬美元，而 2024 年第三季度為 200 萬美元。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li><li>GAAP 淨虧損為 760 萬美元。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li></ul><h3>現金流</h3><ul><li>第三季度自由現金流為 880 萬美元。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li><li>截至 2025 年 9 月 30 日，現金、現金等價物、可出售證券和受限現金為 1.561 億美元。<span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025earningspresentati.htm"></span></li><li>通過 “市場發行” 銷售 101,367 股 A 類普通股，扣除費用後獲得 1180 萬美元。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li></ul><h3>展望/指導</h3><ul><li>GeneDx 提高了 2025 年全年收入指導，預計收入在 4.25 億至 4.28 億美元之間，外顯子組和基因組收入增長在 53% 至 55% 之間。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span><span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025earningspresentati.htm"></span></li><li>調整後的毛利率預計在 70% 至 71% 之間。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span><span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025earningspresentati.htm"></span></li><li>調整後的淨收入預計每季度和全年為正。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span><span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025earningspresentati.htm"></span></li></ul>

GeneDx - CW27｜8-K：2025 財年 Q3 營收 1.17 億美元